Thursday, October 30, 2025

Psyched Wellness Launches Study On Mushroom Extract Focused On Gut Health

Psyched Wellness (CSE: PSYC) this morning issued a very brief press release related to ongoing studies. The firm has initiated yet another study on its proprietary AME-1 extract, this time with the study focused on gut health.

To be conducted through the firms contract research organization, KGK Sciences, the study will look to further examine the anti-inflammatory nature of the firms Amanita Muscaria extract, AME-1. Effectively, the study is to advance the preliminary findings that identified the extract as having such anti-inflammatory properties.

With respect to its anti-inflammatory properties, the research is to place an emphasis on gut health, whereby the compound will be examined for having properties that may enhance digestive barrier function and immunity. Such functions are impaired when gut health is damaged, which can lead to inflammation and chronic conditions. The study will lay groundwork for future preclinical research to be conducted by the company.

Psyched Wellness last traded at $0.295 on the CSE.


FULL DISCLOSURE: Psyched Wellness is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Psyched Wellness on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Silver’s Finally Breaking the System | Keith Neumeyer – First Majestic

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

Recommended

Silver47 Completes Property-Wide Geochemical, Rock Sampling Program At Adams Plateau, Identifies Numerous Targets

Altamira Gold Identifies Presence Of Second Mineralized Porphyry Body At Cajueiro

Related News

Psyched Wellness To Commence Trading Today

Psyched Wellness (CSE: PSYC) is the latest mushroom issue to hit the CSE, with the...

Thursday, October 22, 2020, 08:36:53 AM

Psyched Wellness Sees Professor David Nutt Move From Advisory Role To Directorship

It appears that Professor David Nutt has a desire to become more involved with that...

Monday, November 16, 2020, 08:11:48 AM

Psyched Wellness To Conduct Stability Tests On Proprietary Mushroom Extract

Psyched Wellness (CSE: PSYC) is progressing with the development of its flagship product, an extract...

Monday, July 26, 2021, 09:28:00 AM

Psyched Wellness Completes Maximum Tolerated Dosage Study For Amanita Muscaria Extract AME-1

Psyched Wellness (CSE: PSYC) this morning issued a brief press release related to the ongoing...

Tuesday, March 2, 2021, 07:24:03 AM

Psyched Wellness Completes First Step In Study Identifying Potential Of Muscimol

Psyched Wellness (CSE: PSYC) has completed the first step in identifying the medicinal potential of...

Thursday, January 14, 2021, 06:58:13 AM